Description of four patients with TRIP11 variants expand the clinical spectrum of odontochondroplasia (ODCD) and demonstrate the existence of common variants
Description of four patients with TRIP11 variants expand the clinical [...]
About admin
This author has not yet filled in any details.So far admin has created 239 blog entries.
X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience
X-linked hypophosphatemia and burosumab: Practical clinical points from the French [...]
Defining a growing and maturing skeleton and its relevance in diseases that affect skeletal growth, such as X-linked hypophosphataemia (XLH)
Defining a growing and maturing skeleton and its relevance in [...]
Oral health-related quality of life in X-linked hypophosphatemia and osteogenesis imperfecta
Oral health-related quality of life in X-linked hypophosphatemia and osteogenesis [...]
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial [...]
Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia
Lower Limb Deformity and Gait Deviations Among Adolescents and Adults [...]
Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review
Burden of disease and clinical targets in adult patients with [...]
Impact of Early Conventional Treatment on Adult Bone and Joints in a Murine Model of X-Linked Hypophosphatemia
Impact of Early Conventional Treatment on Adult Bone and Joints [...]
A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders
A Roadmap to Gene Discoveries and Novel Therapies in Monogenic [...]
WNT11, a new gene associated with early-onset osteoporosis, is required for osteoblastogenesis
WNT11, a new gene associated with early-onset osteoporosis, is required [...]
Funded by the European Union
“Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.”
